Histamine dihydrochloride

盐酸组胺

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHistamine dihydrochloride
Drug Alias Name二盐酸组胺Histamino dihidrochloridasHistamini dihydrochloridumHistaminy dichlorowodorekHistamiinidihydrokloridi +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor agonistsNADPH oxidase inhibitors
TargetsHistamine receptorNADPH oxidase
Therapy Area/IndicationsSkin MelanomaHypersensitivityRhinitis, Allergic, Seasonal +[6] 
Global Approved IndicationsLeukemia, Myeloid, Acute
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2008/10/07
Country/TerritoryCanadaUnited StatesSweden +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesImmune Pharmaceuticals IncAlk-Abello Sa
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires DelbertSinopharm A-Think Pharmaceutical Co Ltd
Inactive CompaniesMaxim Pharmaceuticals IncLaboratorios Leti Sl
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsSkin MelanomaHypersensitivityRhinitis, Allergic, Seasonal +[5] 

Other Information

ATC CodeL03AX14
Related LinksWikipediaDrugBankKEGG